BlackRock’s Imunon IMNN Stock Holding History

BlackRock’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1K	Hold	4,464	–	–	﹤0.01%	5371
2025 Q4	$17K	Hold	4,464	–	–	﹤0.01%	5238
2025 Q3	$22.9K	Hold	4,464	–	–	﹤0.01%	5125
2025 Q2	$46.6K	Hold	4,464	–	–	﹤0.01%	5001
2025 Q1	$61.1K	Hold	4,464	–	–	﹤0.01%	4874
2024 Q4	$55.3K	Hold	4,464	–	–	﹤0.01%	4917
2024 Q3	$61.7K	Hold	4,464	–	–	﹤0.01%	4766
2024 Q2	$67.5K	Hold	4,464	–	–	﹤0.01%	4793
2024 Q1	$95.5K	Sell	4,464 -27	-0.6%	-$257	﹤0.01%	4742
2023 Q4	$39.8K	Hold	4,491	–	–	﹤0.01%	4993
2023 Q3	$57.6K	Sell	4,491 -658	-13%	-$10.3K	﹤0.01%	4975
2023 Q2	$86.6K	Buy	5,149 +4	+0.1%	+$66	﹤0.01%	4960
2023 Q1	$83.2K	Sell	5,145 -11	-0.2%	-$211	﹤0.01%	5000
2022 Q4	$90.8K	Sell	5,156 -15	-0.3%	-$289	﹤0.01%	5070
2022 Q3	$113K	Sell	5,171 -22	-0.4%	-$617	﹤0.01%	5146
2022 Q2	$125K	Sell	5,193 -551	-10%	-$20.2K	﹤0.01%	5170
2022 Q1	$379K	Buy	5,744 +58	+1%	+$4.55K	﹤0.01%	4951
2021 Q4	$601K	Buy	5,686 +62	+1%	+$9.66K	﹤0.01%	4825
2021 Q3	$1.02M	Sell	5,624 -62	-1%	-$12.9K	﹤0.01%	4549
2021 Q2	$1.41M	Sell	5,686 -106	-2%	-$25.1K	﹤0.01%	4407
2021 Q1	$1.56M	Buy	5,792 +2,167	+60%	+$728K	﹤0.01%	4371
2020 Q4	$504K	Buy	3,625 +15	+0.4%	+$1.8K	﹤0.01%	4349
2020 Q3	$516K	Sell	3,610 -43	-1%	-$10.9K	﹤0.01%	4259
2020 Q2	$2.66M	Buy	3,653 +2,935	+409%	+$1.27M	﹤0.01%	3739
2020 Q1	$127K	Sell	718 -13	-2%	-$3.26K	﹤0.01%	4314
2019 Q4	$244K	Sell	731 -2	-0.3%	-$607	﹤0.01%	4293
2019 Q3	$221K	Sell	733 -15	-2%	-$5.13K	﹤0.01%	4315
2019 Q2	$267K	Buy	748 +36	+5%	+$14.7K	﹤0.01%	4319
2019 Q1	$273K	Sell	712 -16	-2%	-$6.63K	﹤0.01%	4196
2018 Q4	$202K	Buy	728 +131	+22%	+$54.4K	﹤0.01%	4231
2018 Q3	$323K	Buy	597 +10	+2%	+$5.51K	﹤0.01%	4225
2018 Q2	$339K	Buy	587 +246	+72%	+$122K	﹤0.01%	4194
2018 Q1	$149K	Buy	341 +2	+0.6%	+$962	﹤0.01%	4268
2017 Q4	$177K	Hold	339	–	–	﹤0.01%	4233
2017 Q3	$100K	Hold	339	–	–	﹤0.01%	4361
2017 Q2	$136K	Sell	339 -41	-11%	-$26.2K	﹤0.01%	4343
2017 Q1	$300K	Buy	380 +379	+37,900%	+$326K	﹤0.01%	4113
2016 Q4	$1K	Hold	1	–	–	﹤0.01%	3687
2016 Q3	$3K	Hold	1	–	–	﹤0.01%	3563
2016 Q2	$3K	Hold	1	–	–	﹤0.01%	3586
2016 Q1	$3K	Hold	1	–	–	﹤0.01%	3410
2015 Q4	$4K	Buy	+1	New	+$5.13K	﹤0.01%	3204

Other funds holding IMNN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RCA

Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

BlackRock's IMNN Position: Q1 2026 in Review

BlackRock held its Imunon (IMNN) position steady in Q1 2026 at 4,464 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5371.

BlackRock first reported a position in IMNN in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.66M in Q2 2020. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

BlackRock held 4,464 shares of Imunon worth $13.1K as of Q1 2026.
BlackRock left its Imunon share count unchanged in Q1 2026.
Imunon made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5371 holding.
BlackRock first reported a position in Imunon in Q4 2015 and has held it in 42 quarters since.
BlackRock's Imunon position peaked at $2.66M in Q2 2020.
19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.